BCRX - Biocryst Pharmaceuticals Inc Options

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: VRTX REGN IONS ALNY SRPT PTCT BMRN CRSP BLUE RARE

| Held by: VTI XBI IWM VB VXF VBK IBB IWO CALF SCHA

Scroll to Statements

Index	RUT	P/E	7.64	EPS (ttm)	1.20	Insider Own	9.72%	Shs Outstand	254.11M	Perf Week	2.80%
Market Cap	2.34B	Forward P/E	19.54	EPS next Y	0.47	Insider Trans	-1.65%	Shs Float	229.40M	Perf Month	-2.03%
Enterprise Value	2.54B	PEG	-	EPS next Q	0.04	Inst Own	79.36%	Short Float	16.80%	Perf Quarter	39.67%
Income	263.86M	P/S	2.67	EPS this Y	-77.64%	Inst Trans	3.14%	Short Ratio	7.44	Perf Half Y	25.72%
Sales	874.84M	P/B	-	EPS next Y	73.81%	ROA	52.53%	Short Interest	38.53M	Perf YTD	17.82%
Book/sh	-0.56	P/C	8.49	EPS next 5Y	-27.57%	ROE	-	52W High	11.31 -18.74%	Perf Year	5.51%
Cash/sh	1.08	P/FCF	7.13	EPS past 3/5Y	- -	ROIC	82.95%	52W Low	6.00 53.17%	Perf 3Y	22.37%
Dividend Est.	-	EV/EBITDA	7.41	Sales past 3/5Y	47.82% 117.89%	Gross Margin	97.66%	Volatility	3.82% 4.21%	Perf 5Y	-21.01%
Dividend TTM	-	EV/Sales	2.90	EPS Y/Y TTM	390.89%	Oper. Margin	38.98%	ATR (14)	0.40	Perf 10Y	181.90%
Dividend Ex-Date	-	Quick Ratio	2.03	Sales Y/Y TTM	94.10%	Profit Margin	30.16%	RSI (14)	51.71	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.06	EPS Q/Q	967.80%	SMA20	-0.87%	Beta	0.57	Target Price	21.40
Payout	0.00%	Debt/Eq	-	Sales Q/Q	209.09%	SMA50	2.14%	Rel Volume	0.44	Prev Close	9.16
Employees	435	LT Debt/Eq	-	Earnings	May 06 BMO	SMA200	16.65%	Avg Volume	5.18M	Price	9.19
IPO	Mar 04, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	2218.84% 168.66%	Trades		Volume	2,275,325	Change	0.33%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)